GO Term |
---|
sphingolipid biosynthetic process |
3-keto-sphinganine metabolic process |
GO Term |
---|
endoplasmic reticulum |
endoplasmic reticulum membrane |
extracellular space |
membrane |
GO Term |
---|
3-dehydrosphinganine reductase activity |
Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
212 |
|
Pathway Name | Organism |
---|---|
Sphingolipid de novo biosynthesis | Homo sapiens |
DO ID | Disease Name | Source |
---|---|---|
DOID:0050387 | nonpapillary renal cell carcinoma | |
DOID:0050428 | nonepidermolytic palmoplantar keratoderma | |
DOID:0050467 | erythrokeratodermia variabilis | |
DOID:0050486 | exanthem | |
DOID:0050745 | diffuse large B-cell lymphoma | |
DOID:0050873 | follicular lymphoma | |
DOID:0060281 | photosensitive epilepsy | |
DOID:0080250 | erythrokeratodermia variabilis et progressiva 4 | |
DOID:0111195 | erythrokeratodermia variabilis et progressiva 1 | |
DOID:10003 | sensorineural hearing loss |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024